PARP1 and perinatal asphyxia: PARP-1 overactivation leads to NAD+ exhaustion, worsening the energy crisis, which is the basis for the hypothesis that PARP-1 is a suitable target for therapeutic interventions preventing the long-term effects of perinatal asphyxia, nicotinamide being a prototype for counteracting PARP-1 overactivation.